Vively has raised $1.6 million and partnered with Bupa to bring continuous glucose monitors to the masses. For founder Tim Veron, it’s personal.
Vively co-founder Tim Veron
Key Takeaways
Vively announces it has raised $1.6 million in seed funding, led by Archangel Ventures with participation from Bupa Ventures and others.
Vively has partnered with Bupa’s health insurance arm to bring the cost of a continuous glucose monitors (CGM) with the Vively app and dietician coaching down to $99.
Previously, CGMs were hard to get without a doctor’s prescription to treat diabetes.
A study in Nature of 2,217 people ranging from healthy to diabetic showed that the majority lost weight and improved…
